National Health Investors, Inc. (NHI) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of National Health Investors, Inc. (NYSE:NHI) from a hold rating to a buy rating in a research note issued to investors on Friday. The firm currently has $86.00 target price on the real estate investment trust’s stock.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

A number of other equities research analysts have also commented on the company. Capital One Financial Corporation assumed coverage on National Health Investors in a research report on Monday, October 23rd. They issued an equal weight rating on the stock. BMO Capital Markets reiterated a hold rating and issued a $80.00 target price on shares of National Health Investors in a research report on Wednesday, October 18th. SunTrust Banks, Inc. started coverage on National Health Investors in a research report on Tuesday, October 10th. They issued a hold rating and a $80.00 target price on the stock. Mizuho restated a hold rating and issued a $82.00 price objective on shares of National Health Investors in a research report on Wednesday, October 4th. Finally, Stifel Nicolaus restated a buy rating and issued a $82.00 price objective on shares of National Health Investors in a research report on Wednesday, October 4th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company’s stock. The stock presently has an average rating of Hold and a consensus price target of $80.14.

Shares of National Health Investors (NYSE NHI) opened at $76.66 on Friday. The company has a market capitalization of $3,183.85, a P/E ratio of 14.71, a P/E/G ratio of 3.80 and a beta of 0.58. National Health Investors has a 52-week low of $67.33 and a 52-week high of $81.21. The company has a debt-to-equity ratio of 0.84, a current ratio of 12.72 and a quick ratio of 12.72.

ILLEGAL ACTIVITY WARNING: This piece of content was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this piece of content on another website, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://ledgergazette.com/2017/11/13/national-health-investors-inc-nhi-upgraded-at-zacks-investment-research.html.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 31st. Shareholders of record on Friday, December 29th will be given a $0.95 dividend. The ex-dividend date is Thursday, December 28th. This represents a $3.80 annualized dividend and a yield of 4.96%. National Health Investors’s dividend payout ratio is presently 95.00%.

In other National Health Investors news, insider Kevin Carlton Pascoe sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $79.80, for a total value of $159,600.00. Following the sale, the insider now owns 21,228 shares in the company, valued at approximately $1,693,994.40. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 5.19% of the company’s stock.

Large investors have recently made changes to their positions in the company. Jacobi Capital Management LLC lifted its position in shares of National Health Investors by 187.7% during the 3rd quarter. Jacobi Capital Management LLC now owns 1,827 shares of the real estate investment trust’s stock valued at $142,000 after buying an additional 1,192 shares in the last quarter. Carroll Financial Associates Inc. purchased a new position in shares of National Health Investors during the 2nd quarter valued at approximately $158,000. Fortaleza Asset Management Inc. lifted its position in shares of National Health Investors by 123.7% during the 3rd quarter. Fortaleza Asset Management Inc. now owns 2,740 shares of the real estate investment trust’s stock valued at $212,000 after buying an additional 1,515 shares in the last quarter. Yorktown Management & Research Co Inc purchased a new position in shares of National Health Investors during the 2nd quarter valued at approximately $214,000. Finally, Allegis Investment Advisors LLC purchased a new position in shares of National Health Investors during the 2nd quarter valued at approximately $216,000. Hedge funds and other institutional investors own 70.14% of the company’s stock.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply